Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin MacBeath

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Molecular Systems Biology|January 22, 2009
Linear combinations of docking affinities explain quantitative differences in RTK signalingAndrew Gordus, Jordan A Krall, Elsa M Beyer, et al.
Molecular Cancer Therapeutics|August 28, 2015
Seribantumab, an Anti-ERBB3 Antibody, Delays the Onset of Resistance and Restores Sensitivity to Letrozole in an Estrogen Receptor-Positive Breast Cancer ModelMichael D Curley, Gauri J Sabnis, Lucia Wille, et al.
NPJ Systems Biology and Applications|September 26, 2017
Predicting ligand-dependent tumors from multi-dimensional signaling featuresHelge Hass, Kristina Masson, Sibylle Wohlgemuth, et al.
The American Journal of Pathology|September 17, 2013
Single-cell quantitative HER2 measurement identifies heterogeneity and distinct subgroups within traditionally defined HER2-positive patientsMatthew D Onsum, Elena Geretti, Violette Paragas, et al.
The Journal of Biological Chemistry|August 16, 2014
Systematic analysis of bacterial effector-postsynaptic density 95/disc large/zonula occludens-1 (PDZ) domain interactions demonstrates Shigella OspE protein promotes protein kinase C activation via PDLIM proteinsChae-ryun Yi, John E Allen, Brian Russo, et al.
Cancer|July 22, 2015
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinomaGuoqing Qian, Ning Jiang, Dongsheng Wang, et al.
Cell Reports|March 13, 2013
Suppression of host p53 is critical for Plasmodium liver-stage infectionAlexis Kaushansky, Albert S Ye, Laura S Austin, et al.
Investigational New Drugs|November 18, 2016
A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecanJames M Cleary, Autumn J McRee, Geoffrey I Shapiro, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Vertical silicon nanowires as a universal platform for delivering biomolecules into living cellsAlex K Shalek, Jacob T Robinson, Ethan S Karp, et al.
Molecular Cancer Therapeutics|April 22, 2014
Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinomaNing Jiang, Dongsheng Wang, Zhongliang Hu, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Molecular Systems Biology|January 22, 2009
Linear combinations of docking affinities explain quantitative differences in RTK signalingAndrew Gordus, Jordan A Krall, Elsa M Beyer, et al.
Molecular Cancer Therapeutics|August 28, 2015
Seribantumab, an Anti-ERBB3 Antibody, Delays the Onset of Resistance and Restores Sensitivity to Letrozole in an Estrogen Receptor-Positive Breast Cancer ModelMichael D Curley, Gauri J Sabnis, Lucia Wille, et al.
NPJ Systems Biology and Applications|September 26, 2017
Predicting ligand-dependent tumors from multi-dimensional signaling featuresHelge Hass, Kristina Masson, Sibylle Wohlgemuth, et al.
The American Journal of Pathology|September 17, 2013
Single-cell quantitative HER2 measurement identifies heterogeneity and distinct subgroups within traditionally defined HER2-positive patientsMatthew D Onsum, Elena Geretti, Violette Paragas, et al.
The Journal of Biological Chemistry|August 16, 2014
Systematic analysis of bacterial effector-postsynaptic density 95/disc large/zonula occludens-1 (PDZ) domain interactions demonstrates Shigella OspE protein promotes protein kinase C activation via PDLIM proteinsChae-ryun Yi, John E Allen, Brian Russo, et al.
Cancer|July 22, 2015
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinomaGuoqing Qian, Ning Jiang, Dongsheng Wang, et al.
Cell Reports|March 13, 2013
Suppression of host p53 is critical for Plasmodium liver-stage infectionAlexis Kaushansky, Albert S Ye, Laura S Austin, et al.
Investigational New Drugs|November 18, 2016
A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecanJames M Cleary, Autumn J McRee, Geoffrey I Shapiro, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Vertical silicon nanowires as a universal platform for delivering biomolecules into living cellsAlex K Shalek, Jacob T Robinson, Ethan S Karp, et al.
Molecular Cancer Therapeutics|April 22, 2014
Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinomaNing Jiang, Dongsheng Wang, Zhongliang Hu, et al.
Pageof 6